<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28401</article-id><article-id pub-id-type="doi">10.7554/eLife.28401</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-75834"><name><surname>Wang</surname><given-names>Hansen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-90380"><name><surname>Muiznieks</surname><given-names>Lisa D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90381"><name><surname>Ghosh</surname><given-names>Punam</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-75835"><name><surname>Williams</surname><given-names>Declan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90382"><name><surname>Solarski</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90383"><name><surname>Fang</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90384"><name><surname>Ruiz-Riquelme</surname><given-names>Alejandro</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6581-7132</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40981"><name><surname>Pomès</surname><given-names>Régis</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3068-9833</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-75838"><name><surname>Watts</surname><given-names>Joel C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90385"><name><surname>Chakrabartty</surname><given-names>Avi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17519"><name><surname>Wille</surname><given-names>Holger</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5102-8706</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-90386"><name><surname>Sharpe</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-64190"><name><surname>Schmitt-Ulms</surname><given-names>Gerold</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6962-0919</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Tanz Centre for Research in Neurodegenerative Diseases</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Molecular Medicine Program, Research Institute</institution>, <institution>The Hospital for Sick Children</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Department of Medical Biophysics</institution>, <institution>University of Toronto</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Alberta</institution>, <addr-line><named-content content-type="city">Edmonton</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1032"><name><surname>Schekman</surname><given-names>Randy</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>g.schmittulms@utoronto.ca</email> (GS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>06</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e28401</elocation-id><history><date date-type="received"><day>18</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>06</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Wang et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-28401-v1.pdf"/><abstract><p>The amyloid β peptide (Aβ) is a key player in the etiology of Alzheimer disease (AD), yet a systematic investigation of its molecular interactions has not been reported. Here we identified by quantitative mass spectrometry proteins in human brain extract that bind to oligomeric Aβ1-42 (oAβ1-42) and/or monomeric Aβ1-42 (mAβ1-42) baits. Remarkably, the cyclic neuroendocrine peptide somatostatin-14 (SST14) was observed to be the most selectively enriched oAβ1-42 binder. The binding interface comprises a central tryptophan within SST14 and the N-terminus of Aβ1-42. The presence of SST14 inhibited Aβ aggregation and masked the ability of several antibodies to detect Aβ. Notably, Aβ1-42, but not Aβ1-40, formed in the presence of SST14 oligomeric assemblies of 50 to 60 kDa that were visualized by gel electrophoresis, nanoparticle tracking analysis and electron microscopy. These findings may be relevant for Aβ-directed diagnostics and may signify a role of SST14 in the etiology of AD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Schmitt-Ulms</surname><given-names>Gerold</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009011</institution-id><institution>Ontario Centres for Excellence</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sharpe</surname><given-names>Simon</given-names></name><name><surname>Schmitt-Ulms</surname><given-names>Gerold</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006677</institution-id><institution>Alberta Innovates Bio Solutions</institution></institution-wrap></funding-source><award-id>201600028</award-id><principal-award-recipient><name><surname>Wille</surname><given-names>Holger</given-names></name><name><surname>Schmitt-Ulms</surname><given-names>Gerold</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004411</institution-id><institution>Heart and Stroke Foundation of Canada</institution></institution-wrap></funding-source><award-id>G-15-0009148</award-id><principal-award-recipient><name><surname>Sharpe</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000196</institution-id><institution>Canada Foundation for Innovation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Schmitt-Ulms</surname><given-names>Gerold</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hansen Wang, Holds provisionary US patent on amyloid-beta binding polypeptides based on the results of this study (filing number 62/451,309)..</p></fn><fn fn-type="conflict" id="conf3"><p>Gerold Schmitt-Ulms, Holds provisionary US patent on amyloid-beta binding polypeptides based on the results of this study (filing number 62/451,309).</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The work was performed in strict accordance with University of Toronto animal care and biosafety recommendations. All mice were handled according to procedures approved (AUP4183.3) by the animal care committee at University Health Network overseeing work at the Krembil Discovery Centre (Toronto). The handling of samples and reagents followed biosafety procedures approved (208-S06-2) by the University of Toronto Biosafety Program.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="http://www.ebi.ac.uk/pride" source-id-type="uri"><collab>Gerold Schmitt-Ulms</collab>, <collab>Declan Williams</collab>, <year>2016</year><x>,</x> <source>The human amyloid beta peptide interactome</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride">http://www.ebi.ac.uk/pride</ext-link><x>,</x> <comment>PXD004867</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-28401-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>